Loading...
Please wait, while we are loading the content...
Similar Documents
Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Li, Jing Kim, Kyungho Hahm, Eunsil Molokie, Robert Hay, Nissim Gordeuk, Victor R. Du, Xiaoping Cho, Jaehyung |
| Copyright Year | 2014 |
| Abstract | Interactions between platelets, leukocytes, and activated endothelial cells are important during microvascular occlusion; however, the regulatory mechanisms of these heterotypic cell-cell interactions remain unclear. Here, using intravital microscopy to evaluate mice lacking specific isoforms of the serine/threonine kinase AKT and bone marrow chimeras, we found that hematopoietic cell-associated AKT2 is important for neutrophil adhesion and crawling and neutrophil-platelet interactions on activated endothelial cells during TNF-α-induced venular inflammation. Studies with an AKT2-specific inhibitor and cells isolated from WT and Akt KO mice revealed that platelet- and neutrophil-associated AKT2 regulates heterotypic neutrophil-platelet aggregation under shear conditions. In particular, neutrophil AKT2 was critical for membrane translocation of αMβ2 integrin, β2-talin1 interaction, and intracellular Ca2+ mobilization. We found that the basal phosphorylation levels of AKT isoforms were markedly increased in neutrophils and platelets isolated from patients with sickle cell disease (SCD), an inherited hematological disorder associated with vascular inflammation and occlusion. AKT2 inhibition reduced heterotypic aggregation of neutrophils and platelets isolated from SCD patients and diminished neutrophil adhesion and neutrophil-platelet aggregation in SCD mice, thereby improving blood flow rates. Our results provide evidence that neutrophil AKT2 regulates αMβ2 integrin function and suggest that AKT2 is important for neutrophil recruitment and neutrophil-platelet interactions under thromboinflammatory conditions such as SCD. |
| Starting Page | 843 |
| Ending Page | 843 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://www.jci.org/articles/view/72305/version/2/pdf/render |
| Alternate Webpage(s) | http://www.jci.org/articles/view/72305/version/2/pdf/render |
| Alternate Webpage(s) | http://dm5migu4zj3pb.cloudfront.net/manuscripts/72000/72305/JCI72305.v2.pdf |
| PubMed reference number | 24642468v1 |
| Alternate Webpage(s) | https://doi.org/10.1172/JCI72305 |
| DOI | 10.1172/jci72305 |
| Journal | The Journal of clinical investigation |
| Volume Number | 124 |
| Issue Number | 4 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | AKT2 gene Anemia, Sickle Cell Blood Platelets Bone Marrow Calcium ion Cell Communication Chimera organism Hematological Disease Inflammation MARK2 gene Neutrophil Infiltration Patients Protein Isoforms Protein-Serine-Threonine Kinases Proto-Oncogene Proteins c-akt Threonine Tissue membrane Vascular Diseases vascular inflammations |
| Content Type | Text |
| Resource Type | Article |